Profile data is unavailable for this security.
About the company
Rite Aid Corporation is a healthcare company that operates retail drugstore chain. The Company is principally engaged in providing its service to customers and communities through various programs. Its business segments include Retail Pharmacy segment and Pharmacy Services segment. Retail Pharmacy segment sells brand and generic prescription drugs and various other pharmacy services, as well as front-end products, including health and beauty aids, personal care products and seasonal merchandise. Its Retail Pharmacy segment operates approximately 2,300 retail pharmacy locations across 17 states. Pharmacy Services segment provides a range of pharmacy benefit services through Elixir. Elixir also offers integrated mail-order and specialty pharmacy services through Elixir Pharmacy. The Pharmacy Services segment provides both transparent and traditional pharmacy benefit management (PBM) options through its Elixir PBM. The Company's clients include employers, insurance companies and unions.
- Revenue in USD (TTM)24.21bn
- Net income in USD-866.60m
- Incorporated1968
- Employees53.00k
- LocationRite Aid Corp1200 INTREPID AVENUE, 2ND FLOORPHILADELPHIA 19112United StatesUSA
- Phone+1 (717) 761-2633
- Fax+1 (302) 655-5049
- Websitehttps://www.riteaid.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Homology Medicines Inc | 3.21m | -4.29m | 86.80m | 224.00 | -- | 0.4152 | 29.57 | 27.06 | -0.0915 | -0.0915 | 0.0559 | 3.64 | 0.013 | -- | -- | 14,321.43 | -0.0657 | -38.19 | -0.0721 | -41.16 | -- | -- | -5.05 | -948.08 | -- | -- | 0.00 | -- | 1,157.25 | -- | 25.59 | -- | 3.79 | -- |
| CareRx Corp | 285.27m | -25.33m | 88.88m | 1.38k | -- | 1.98 | -- | 0.3116 | -0.7298 | -0.7298 | 8.27 | 1.24 | 1.42 | 13.98 | 9.82 | 278,852.00 | -12.64 | -17.30 | -15.90 | -36.93 | 28.69 | 29.97 | -8.88 | -15.99 | 1.20 | 0.6716 | 0.70 | -- | 61.92 | 9.43 | -25.01 | -- | 19.31 | -- |
| Tabula Rasa HealthCare Inc | 302.49m | -80.33m | 118.80m | 1.60k | -- | -- | -- | 0.3928 | -3.36 | -5.81 | 12.65 | -1.17 | 0.6686 | 42.44 | 7.82 | 188,822.10 | -17.76 | -12.97 | -21.67 | -15.22 | 23.80 | 31.98 | -26.56 | -18.17 | 1.78 | -6.37 | 1.11 | -- | 11.45 | 28.43 | 2.36 | -- | 43.94 | -- |
| High Tide Inc | 224.55m | -17.60m | 122.29m | -- | -- | 0.8111 | 48.03 | 0.5446 | -0.3972 | -0.3972 | 5.11 | 2.87 | 1.11 | 11.07 | 34.38 | -- | -8.28 | -- | -10.07 | -- | 29.42 | -- | -7.45 | -- | 0.7777 | -5.05 | 0.2378 | -- | 117.53 | -- | -412.59 | -- | -- | -- |
| Marimed Inc | 129.22m | 2.21m | 176.46m | 260.00 | 152.94 | 3.31 | 26.46 | 1.37 | 0.0034 | 0.0034 | 0.351 | 0.2685 | 0.9829 | 4.48 | 16.93 | 497,014.90 | 1.87 | -27.01 | 2.28 | -39.39 | 49.24 | 54.25 | 1.90 | -36.53 | 0.8284 | 20.64 | 0.2289 | -- | 138.66 | 102.53 | 236.97 | -- | 40.72 | -- |
| HLS Therapeutics Inc | 61.47m | -21.35m | 244.20m | 94.00 | -- | 1.86 | 19.70 | 3.97 | -0.8863 | -0.8863 | 2.55 | 5.46 | 0.2302 | 0.4627 | 6.90 | 900,043.00 | -8.00 | -5.38 | -9.03 | -6.09 | 92.54 | 94.70 | -34.74 | -25.72 | 1.14 | -3.02 | 0.4313 | -- | 6.95 | -- | 14.44 | -- | -- | -- |
| Rite Aid Corporation | 24.21bn | -866.60m | 288.90m | 53.00k | -- | -- | -- | 0.0119 | -15.94 | -15.94 | 445.71 | -5.95 | 2.73 | 9.84 | 15.01 | 456,791.00 | -9.78 | -3.96 | -14.30 | -5.77 | 20.35 | 21.12 | -3.58 | -1.58 | 0.6083 | 0.5526 | 1.12 | -- | 2.18 | 1.39 | -438.10 | -- | -5.56 | -- |
| Petmed Express Inc | 262.30m | 15.68m | 409.08m | 212.00 | 25.17 | 2.96 | 21.89 | 1.56 | 0.7712 | 0.7712 | 12.91 | 6.55 | 1.60 | 6.95 | 152.32 | 1,237,264.00 | 9.54 | 19.33 | 11.13 | 23.28 | 28.79 | 31.07 | 5.98 | 10.54 | 3.41 | -- | 0.00 | 72.36 | -11.58 | 1.87 | -31.05 | -2.40 | -30.24 | 9.57 |
| Neighbourly Pharmacy Inc | 404.42m | 4.61m | 810.46m | 2.04k | 133.01 | 1.76 | 28.19 | 2.00 | 0.1853 | 0.1853 | 14.99 | 14.04 | 0.673 | 4.94 | 20.19 | 267,558.00 | 0.9049 | -- | 1.02 | -- | 37.70 | -- | 1.34 | -- | 0.6005 | 2.00 | 0.3228 | -- | 39.48 | -- | 19.68 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2022 | 3.93m | 6.95% |
| BlackRock Fund Advisorsas of 30 Sep 2022 | 3.44m | 6.09% |
| Invesco Advisers, Inc.as of 30 Sep 2022 | 2.50m | 4.43% |
| SSgA Funds Management, Inc.as of 30 Sep 2022 | 1.84m | 3.26% |
| GMT Capital Corp.as of 30 Sep 2022 | 1.48m | 2.62% |
| Two Sigma Advisers LPas of 30 Sep 2022 | 991.95k | 1.76% |
| Geode Capital Management LLCas of 30 Sep 2022 | 965.50k | 1.71% |
| Charles Schwab Investment Management, Inc.as of 30 Sep 2022 | 841.32k | 1.49% |
| Bridgeway Capital Management LLCas of 30 Sep 2022 | 797.10k | 1.41% |
| Susquehanna Financial Group LLLPas of 30 Sep 2022 | 782.74k | 1.39% |
